Public Profile

RECORDATI

Recordati S.p.A., a prominent player in the pharmaceutical industry, is headquartered in Luxembourg (LU) and operates extensively across Europe, North America, and other global markets. Founded in 1926, Recordati has established itself as a leader in the development and marketing of innovative medicines, particularly in the fields of rare diseases and specialty pharmaceuticals. The company’s core offerings include a diverse range of prescription drugs, with a strong emphasis on treatments for rare diseases, urology, and cardiovascular conditions. Recordati's commitment to research and development sets it apart, enabling the introduction of unique therapies that address unmet medical needs. With a robust market position, Recordati has achieved significant milestones, including strategic acquisitions and partnerships that enhance its portfolio and global reach.

DitchCarbon Score

How does RECORDATI's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

66

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

RECORDATI's score of 66 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.

99%

Let us know if this data was useful to you

RECORDATI's reported carbon emissions

In 2024, RECORDATI reported total carbon emissions of approximately 346,511,000 kg CO2e. This includes Scope 1 emissions of about 37,280,000 kg CO2e, Scope 2 emissions of approximately 1,714,000 kg CO2e (market-based), and significant Scope 3 emissions of around 307,517,000 kg CO2e. The company has set ambitious targets to reduce its emissions, aiming for a 30% reduction in both Scope 1 and Scope 2 emissions from a 2021 baseline by 2030. Additionally, RECORDATI is committed to sourcing 100% of its electricity from renewable sources for its production and packaging sites by 2025. In 2023, RECORDATI achieved a reduction of about 3.1% in Scope 1 emissions and approximately 1.9% in Scope 2 emissions compared to the previous year. The company has also committed to a more aggressive target of a 42% reduction in Scope 1 and Scope 2 emissions by 2030, based on 2023 levels, while also focusing on measuring and reducing its Scope 3 emissions. RECORDATI's climate commitments reflect a strong dedication to sustainability and align with industry standards for reducing greenhouse gas emissions, contributing to global efforts to combat climate change.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20172018201920202021202220232024
Scope 1
34,458,000
00,000,000
00,000,000
00,000,000
00,000
00,000,000
00,000,000
00,000,000
Scope 2
12,384,000
00,000,000
0,000,000
0,000,000
0,000
0,000,000
0,000,000
0,000,000
Scope 3
-
-
-
-
-
0,000,000
0,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. RECORDATI's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for RECORDATI is in LU, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

RECORDATI is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Sopharma AD

BG
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Horizon Therapeutics Public Limited Company

IE
Health and social work services (85)
Updated 3 months ago
DitchCarbon Score

Churchill Downs Incorporated

US
Recreational, cultural and sporting services (92)
Updated 6 days ago

Actelion Ltd

CH
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Hikma Pharmaceuticals

GB
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Almirall

ES
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers